Again, Questioning validity of claims of this magnitude , particularly with the type of claims that are being made here that are pertinent to life and death treatments, should not be misconstrued as "negativity"..It should be perceived as a necessary part of validating such claims.
Why would anyone want to buy shares in something making these enormous claims ( particularly at this level) when there's be no validation by the appropriate agencies that it even SOMEWHAT works? We're not talking about triple pennies now. This is serious money that people are being asked to invest.
The company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralize the HIV virus. The monoclonal antibody is projected to be multi billion dollar business. If a biopharma waits much longer they will miss out. Mark it.